Search details
1.
A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models.
Haematologica
; 105(3): 741-753, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31248974
2.
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.
Haematologica
; 104(4): 778-788, 2019 04.
Article
in English
| MEDLINE | ID: mdl-29954928
3.
Selective CXCR4+ Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin.
Small
; 14(26): e1800665, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29845742
4.
Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.
Blood
; 137(7): 994-999, 2021 02 18.
Article
in English
| MEDLINE | ID: mdl-32915956
5.
Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
FASEB J
; 29(2): 464-76, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25359494
6.
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.
J Pathol
; 235(3): 445-55, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25231113
7.
Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models.
Nanomedicine
; 12(7): 1987-1996, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27085904
8.
Focal adhesion protein expression in human diffuse large B-cell lymphoma.
Histopathology
; 65(1): 119-31, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24467224
9.
A novel inhibitor of focal adhesion signaling induces caspase-independent cell death in diffuse large B-cell lymphoma.
Blood
; 118(16): 4411-20, 2011 Oct 20.
Article
in English
| MEDLINE | ID: mdl-21868575
10.
A novel orally available inhibitor of focal adhesion signaling increases survival in a xenograft model of diffuse large B-cell lymphoma with central nervous system involvement.
Haematologica
; 98(8): 1242-9, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23716554
11.
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.
Pharmaceutics
; 15(3)2023 Feb 22.
Article
in English
| MEDLINE | ID: mdl-36986589
12.
Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.
Biomed Pharmacother
; 164: 114976, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37276641
13.
High-precision targeting and destruction of cancer-associated PDGFR-ß+ stromal fibroblasts through self-assembling, protein-only nanoparticles.
Acta Biomater
; 170: 543-555, 2023 Oct 15.
Article
in English
| MEDLINE | ID: mdl-37683965
14.
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.
Cancers (Basel)
; 15(1)2022 Dec 23.
Article
in English
| MEDLINE | ID: mdl-36612081
15.
Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease.
Biomedicines
; 10(7)2022 Jul 12.
Article
in English
| MEDLINE | ID: mdl-35884987
16.
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery.
J Control Release
; 343: 277-287, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35051493
17.
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials.
Pharmaceutics
; 14(1)2022 Jan 14.
Article
in English
| MEDLINE | ID: mdl-35057088
18.
CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
J Exp Clin Cancer Res
; 41(1): 49, 2022 Feb 04.
Article
in English
| MEDLINE | ID: mdl-35120582
19.
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model.
Pharmaceutics
; 14(4)2022 Apr 18.
Article
in English
| MEDLINE | ID: mdl-35456719
20.
GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.
Drug Deliv
; 29(1): 1384-1397, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35532120